In this KRAS mutant context, PDHK4 downregulation did not affect the PDH phosphorylation levels (Ser293 or Ser300), suggesting that PDHK4 could play a previously un-appreciated role in mutant KRAS cancer models. The gene discussed is KRAS; the disease is cancer.